Mycophenolate mofetil

Mycophenolate mofetil, mycophenolate mofetil, 128794-94-5, 115007-34-6, Myfenax, RS 61443, RS-61443, myclausen, Mycophenylate mofetil, Mycophenolic acid morpholinoethyl ester, Mycophenolate mofetil Teva, MYHIBBIN, Arzip, 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate, NSC-724229, NSC-758905, CHEBI:8764, DTXSID3023340, 9242ECW6R0, 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate, DTXCID103340, 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-, NSC724229, MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER, Mofetil, Mycophenolate, RefChem:55675, 627-027-6, CellCept, TM-MMF, 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate, MFCD00867568, 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)-, Cellcept (TN), C23H31NO7, 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate, Mycophenolate mofetil (CellCept), Munoloc, 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate, 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate, (E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate, Mycophenolate Mofetil (E/Z mixture), 1076198-64-5, 2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate, SMR002544686, MMF CellCept(TM), CAS-128794-94-5, HSDB 7436, ME-MPA, SR-05000001485, Mycophenolate mofetil [USAN], UNII-9242ECW6R0, Mycophenolate Mofetil (Rs-61443), Mycophenolatmofetil, Mycophenolate mofetil [USAN:USP], NCGC00159459-02, mycophenolate-mofetil, R-99, Mycophenolate mofetil CRS, SCHEMBL4195, CHEMBL1456, 140401-05-4, MLS003915627, MLS004774133, MLS006011929, 2-(4-morpholinyl)ethyl ester, GTPL6831, orb1300896, orb1310798, orb3141247, SCHEMBL29378681, CHEBI:93612, HY-B0199R, Mycophenolate Mofetil (Standard), Mycophenolate mofetil (JAN/USP), GLXC-06676, HMS2090A03, HMS5079C12, Pharmakon1600-01504567, MYCOPHENOLATE MOFETIL [JAN], ALBB-027273, HY-B0199, MYCOPHENOLATE MOFETIL [HSDB], Tox21_111686, BBL029073, BDBM50248299, EBC-11251, MSK001604, MYCOPHENOLATE MOFETIL [VANDF], NSC758905, s1501, STL146382, MYCOPHENOLATE MOFETIL [MART.], AKOS005720900, MYCOPHENOLATE MOFETIL [USP-RS], MYCOPHENOLATE MOFETIL [WHO-DD], Tox21_111686_1, AC-1562, CCG-213315, DB00688, FM26106, KS-1209, NSC 724229, NSC 758905, MYCOPHENOLATE MOFETIL [EMA EPAR], Mycophenolate mofetil, >=98% (HPLC), NCGC00159459-03, NCGC00159459-04, 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate, BM164622, LS-15013, Mycophenolate mofetil - Bio-X trade mark, SMR004703518, SY057966, MYCOPHENOLATE MOFETIL [ORANGE BOOK], MYCOPHENOLATE MOFETIL [EP MONOGRAPH], M2387, MYCOPHENOLATE MOFETIL [USP MONOGRAPH], NS00006994, SW219893-1, C07908, D00752, SBI-0653417.0001, W18801, AB01274794-01, AB01274794-02, AB01274794_03, AB01274794_04, EN300-1705962, Mycop henolic acid 2-(4-morpholinyl)ethyl ester, Mycophenolate mofetil for peak identification CRS, F802474, Mycophenolate mofetil 100 microg/mL in Acetonitrile, Q4567614, SR-05000001485-1, SR-05000001485-2, BRD-K92428153-001-01-0, BRD-K92428153-001-04-4, BRD-K92428153-001-05-1, Z2568665233, MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER [MI], Mycophenolate mofetil, European Pharmacopoeia (EP) Reference Standard, Mycophenolate mofetil, United States Pharmacopeia (USP) Reference Standard, Mycophenolate mofetil for peak identification, European Pharmacopoeia (EP) Reference Standard, Mycophenolate Mofetil, Pharmaceutical Secondary Standard, Certified Reference Material, (4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)4-HEXENOIC ACID 4-METHYL-2-(4-MORPHOLINYL)ETHYL ESTER, (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester, 2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE, 2-(4-Morpholinyl)ethyl (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate, 2-(Morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex4-enoate, 4-Hexenoic acid,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E), 4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER, morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate, Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate, Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate, Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate